Total Payments
$2,597
2024 Payments
$440.90
Companies
29
Transactions
136
Medicare Patients
592
Medicare Billing
$30,773
Payment Breakdown by Category
Food & Beverage$2,490 (95.9%)
Education$107.35 (4.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,490 | 127 | 95.9% |
| Education | $107.35 | 9 | 4.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $645.87 | 29 | $0 (2024) |
| Aspira Women's Health Inc | $255.24 | 3 | $0 (2021) |
| Astellas Pharma US Inc | $201.43 | 10 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $193.71 | 11 | $0 (2024) |
| Avion Pharmaceuticals | $157.23 | 12 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $121.54 | 8 | $0 (2019) |
| AMAG Pharmaceuticals, Inc. | $107.35 | 9 | $0 (2020) |
| MAYNE PHARMA COMMERCIAL LLC | $96.70 | 5 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $94.03 | 7 | $0 (2023) |
| Mission Pharmacal Company | $75.94 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $440.90 | 22 | Astellas Pharma US Inc ($145.65) |
| 2023 | $502.68 | 31 | ABBVIE INC. ($155.91) |
| 2022 | $99.46 | 6 | ABBVIE INC. ($44.82) |
| 2021 | $367.32 | 10 | Aspira Women's Health Inc ($255.24) |
| 2020 | $247.34 | 10 | AbbVie Inc. ($135.58) |
| 2019 | $399.74 | 27 | Avion Pharmaceuticals ($79.95) |
| 2018 | $404.35 | 21 | AbbVie, Inc. ($185.75) |
| 2017 | $135.25 | 9 | Mission Pharmacal Company ($47.73) |
All Payment Transactions
136 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: Biological | ||||||
| 12/09/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $25.09 | General |
| Category: ETONOGESTREL | ||||||
| 12/06/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: HORMONE THERAPY | ||||||
| 11/15/2024 | Sage Therapeutics, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: PSYCHIATRY/PSYCHOLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: WOMENS HEALTH | ||||||
| 11/08/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: HORMONE THERAPY | ||||||
| 11/04/2024 | Hologic Sales and Service, LLC | APTIMA (Device) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: Diagnostics | ||||||
| 10/31/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: Biological | ||||||
| 10/11/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: HORMONE THERAPY | ||||||
| 10/07/2024 | Sage Therapeutics, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: PSYCHIATRY/PSYCHOLOGY | ||||||
| 10/03/2024 | CooperSurgical, Inc. | Paragard T 380A (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Endocrinology | ||||||
| 09/20/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Biological | ||||||
| 09/13/2024 | Sage Therapeutics, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: PSYCHIATRY/PSYCHOLOGY | ||||||
| 08/19/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: Biological | ||||||
| 07/15/2024 | Evofem Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $20.80 | General |
| 06/06/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: HORMONE THERAPY | ||||||
| 05/30/2024 | CooperSurgical, Inc. | Paragard T 380A (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Endocrinology | ||||||
| 05/03/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: HORMONE THERAPY | ||||||
| 04/10/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Biological | ||||||
| 03/13/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: HORMONE THERAPY | ||||||
| 02/23/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: Biological | ||||||
| 01/03/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Biological | ||||||
| 12/11/2023 | CooperSurgical, Inc. | PARAGARD T 380A (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Endocrinology | ||||||
| 12/08/2023 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: WOMENS HEALTH | ||||||
| 12/07/2023 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $4.80 | General |
| Category: WOMENS HEALTH | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 198 | 212 | $24,327 | $10,241 |
| 2022 | 4 | 156 | 162 | $18,195 | $8,629 |
| 2021 | 4 | 165 | 171 | $15,950 | $8,209 |
| 2020 | 3 | 73 | 75 | $7,325 | $3,695 |
Total Patients
592
Total Services
620
Medicare Billing
$30,773
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 111 | 111 | $8,880 | $4,562 | 51.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 45 | 55 | $11,000 | $3,758 | 34.2% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 31 | 31 | $3,097 | $1,404 | 45.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 15 | $1,350 | $517.22 | 38.3% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 81 | 81 | $6,480 | $3,419 | 52.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 38 | 44 | $6,950 | $2,849 | 41.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 12 | $2,640 | $1,203 | 45.6% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 25 | 25 | $2,125 | $1,158 | 54.5% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 99 | 99 | $7,920 | $4,255 | 53.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 27 | 28 | $4,200 | $1,984 | 47.2% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 26 | 26 | $2,210 | $1,240 | 56.1% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 13 | 18 | $1,620 | $729.78 | 45.0% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 41 | 41 | $3,280 | $1,815 | 55.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 17 | 19 | $2,770 | $1,174 | 42.4% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2020 | 15 | 15 | $1,275 | $706.60 | 55.4% |
About Dr. Manuel Ferreira, MD
Dr. Manuel Ferreira, MD is a Obstetrics & Gynecology healthcare provider based in West Chester, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/04/2010. The National Provider Identifier (NPI) number assigned to this provider is 1770803454.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Manuel Ferreira, MD has received a total of $2,597 in payments from pharmaceutical and medical device companies, with $440.90 received in 2024. These payments were reported across 136 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($2,490).
As a Medicare-enrolled provider, Ferreira has provided services to 592 Medicare beneficiaries, totaling 620 services with total Medicare billing of $30,773. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Location West Chester, PA
- Active Since 06/04/2010
- Last Updated 07/09/2021
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1770803454
Products in Payments
- OVA1 (Device) $255.24
- ORILISSA (Drug) $241.45
- MYFEMBREE (Drug) $238.31
- Veozah (Drug) $201.43
- Balcoltra (Drug) $157.23
- Lupron (Drug) $150.40
- NEXPLANON (Drug) $118.78
- Orilissa (Drug) $114.68
- Mirena (Drug) $78.44
- LILETTA (Drug) $76.12
- CitraNatal (Drug) $75.94
- INTRAROSA (Drug) $72.50
- LO LOESTRIN FE (Drug) $67.47
- ZURZUVAE (Drug) $64.46
- Xulane (Drug) $48.89
- NUVARING (Drug) $45.93
- Phexxi (Drug) $44.14
- Osphena (Drug) $37.96
- Paragard T 380A (Drug) $36.44
- SLYND (Drug) $34.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in West Chester
Mickey Karram, M.d, M.D
Obstetrics & Gynecology — Payments: $452,484
Obstetrics & Gynecology $452,484
Amy Brenner, Md, MD
Obstetrics & Gynecology — Payments: $38,296
Obstetrics & Gynecology $38,296
Dr. Sarah Sabin, M.d, M.D
Obstetrics & Gynecology — Payments: $4,858
Obstetrics & Gynecology $4,858
Dr. Natalia Stovall, M.d, M.D
Obstetrics & Gynecology — Payments: $3,376
Obstetrics & Gynecology $3,376
Dr. Cathleen Brown, D.o, D.O
Obstetrics & Gynecology — Payments: $3,281
Obstetrics & Gynecology $3,281
Hayley Barnes, M.d, M.D
Obstetrics & Gynecology — Payments: $2,831
Obstetrics & Gynecology $2,831